149 related articles for article (PubMed ID: 9192751)
1. Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells.
Higazi AA; Lavi E; Bdeir K; Ulrich AM; Jamieson DG; Rader DJ; Usher DC; Kane W; Ganz T; Cines DB
Blood; 1997 Jun; 89(12):4290-8. PubMed ID: 9192751
[TBL] [Abstract][Full Text] [Related]
2. Defensin promotes the binding of lipoprotein(a) to vascular matrix.
Bdeir K; Cane W; Canziani G; Chaiken I; Weisel J; Koschinsky ML; Lawn RM; Bannerman PG; Sachais BS; Kuo A; Hancock MA; Tomaszewski J; Raghunath PN; Ganz T; Higazi AA; Cines DB
Blood; 1999 Sep; 94(6):2007-19. PubMed ID: 10477730
[TBL] [Abstract][Full Text] [Related]
3. The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis.
Higazi AA; Nassar T; Ganz T; Rader DJ; Udassin R; Bdeir K; Hiss E; Sachais BS; Williams KJ; Leitersdorf E; Cines DB
Blood; 2000 Aug; 96(4):1393-8. PubMed ID: 10942383
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation.
Jamieson DG; Usher DC; Rader DJ; Lavi E
Am J Pathol; 1995 Dec; 147(6):1567-74. PubMed ID: 7495281
[TBL] [Abstract][Full Text] [Related]
5. Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells.
Higazi AA; Ganz T; Kariko K; Cines DB
J Biol Chem; 1996 Jul; 271(30):17650-5. PubMed ID: 8663495
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of defensin in human coronary vessels.
Barnathan ES; Raghunath PN; Tomaszewski JE; Ganz T; Cines DB; Higazi A al-R
Am J Pathol; 1997 Mar; 150(3):1009-20. PubMed ID: 9060838
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.
Caplice NM; Panetta C; Peterson TE; Kleppe LS; Mueske CS; Kostner GM; Broze GJ; Simari RD
Blood; 2001 Nov; 98(10):2980-7. PubMed ID: 11698280
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin.
Sotiriou SN; Orlova VV; Al-Fakhri N; Ihanus E; Economopoulou M; Isermann B; Bdeir K; Nawroth PP; Preissner KT; Gahmberg CG; Koschinsky ML; Chavakis T
FASEB J; 2006 Mar; 20(3):559-61. PubMed ID: 16403785
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) in cardiovascular diseases.
Malaguarnera M; Vacante M; Russo C; Malaguarnera G; Antic T; Malaguarnera L; Bella R; Pennisi G; Galvano F; Frigiola A
Biomed Res Int; 2013; 2013():650989. PubMed ID: 23484137
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil antimicrobial peptide alpha-defensin causes endothelial dysfunction in porcine coronary arteries.
Kougias P; Chai H; Lin PH; Yao Q; Lumsden AB; Chen C
J Vasc Surg; 2006 Feb; 43(2):357-63. PubMed ID: 16476615
[TBL] [Abstract][Full Text] [Related]
11. Detection of lipoprotein(a) in intraparenchymal cerebral vessels: correlation with vascular pathology and clinical history.
Jamieson DG; Fu L; Usher DC; Lavi E
Exp Mol Pathol; 2001 Oct; 71(2):99-105. PubMed ID: 11599915
[TBL] [Abstract][Full Text] [Related]
12. Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells.
Ren S; Man RY; Angel A; Shen GX
Atherosclerosis; 1997 Jan; 128(1):1-10. PubMed ID: 9051192
[TBL] [Abstract][Full Text] [Related]
13. Expression of adhesion molecules by lp(a): a potential novel mechanism for its atherogenicity.
Allen S; Khan S; Tam Sp; Koschinsky M; Taylor P; Yacoub M
FASEB J; 1998 Dec; 12(15):1765-76. PubMed ID: 9837867
[TBL] [Abstract][Full Text] [Related]
14. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.
Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J
Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416
[TBL] [Abstract][Full Text] [Related]
16. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor.
Argraves KM; Kozarsky KF; Fallon JT; Harpel PC; Strickland DK
J Clin Invest; 1997 Nov; 100(9):2170-81. PubMed ID: 9410893
[TBL] [Abstract][Full Text] [Related]
17. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
[TBL] [Abstract][Full Text] [Related]
18. Proliferation of human smooth muscle cells promoted by lipoprotein(a).
Grainger DJ; Kirschenlohr HL; Metcalfe JC; Weissberg PL; Wade DP; Lawn RM
Science; 1993 Jun; 260(5114):1655-8. PubMed ID: 8503012
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells.
Poon M; Zhang X; Dunsky KG; Taubman MB; Harpel PC
Circulation; 1997 Oct; 96(8):2514-9. PubMed ID: 9355887
[TBL] [Abstract][Full Text] [Related]
20. Conditioned medium from HepG2 cells transfected with human apolipoprotein(a) gene stimulates growth of human vascular smooth muscle cells: effects of overexpression of human apolipoprotein(a) gene.
Morishita R; Yamada S; Higaki J; Tomita N; Kida I; Aoki M; Moriguchi A; Hayashi S; Sakurabayashi I; Kaneda Y; Ogihara T
Hypertension; 1998 Aug; 32(2):215-22. PubMed ID: 9719045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
